Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Dengjel J, Nastke MD, Gouttefangeas C, Gitsioudis G, Schoor O, Altenberend F, Müller M, Krämer B, Missiou A, Sauter M, Hennenlotter J, Wernet D, Stenzl A, Rammensee HG, Klingel K, Stevanović S.
Dengjel J, et al. Among authors: stevanovic s.
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4163-70. doi: 10.1158/1078-0432.CCR-05-2470.
Clin Cancer Res. 2006.
PMID: 16857787